AI assistant
BIO-TECHNE Corp — Director's Dealing 2026
Feb 5, 2026
30718_dirs_2026-02-05_43f23695-5f80-4830-8cc8-96ac09295744.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2026-02-03
Reporting Person: Herr Amy E. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-03 | Common Stock | M | 38 | — | Acquired | 2192 | Indirect |
| 2026-02-03 | Common Stock | F | 16 | $64.63 | Disposed | 2176 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | Restricted Stock Units | $ | M | 38 | Disposed | Common Stock (38) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2680 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (2415) | 2415 | Direct |
| Stock Option (Right to Buy) | $60.96 | 2035-10-30 | Common Stock (3777) | 3777 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (6636) | 6636 | Indirect |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (4472) | 4472 | Indirect |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (2076) | 2076 | Indirect |
| Stock Option (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (2104) | 2104 | Indirect |
| Stock Option (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (1084) | 1084 | Indirect |
| Stock Option (Right to Buy) | $74.91 | 2034-08-15 | Common Stock (1468) | 1468 | Indirect |
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (344) | 344 | Indirect |
| Restricted Stock Units | $ | Common Stock (118) | 118 | Indirect | |
| Restricted Stock Units | $ | Common Stock (320) | 320 | Indirect | |
| Restricted Stock Units | $ | Common Stock (932) | 932 | Indirect | |
| Stock Option (Right to Buy) | $53.60 | 2035-08-15 | Common Stock (2735) | 2735 | Indirect |
Footnotes
F1: This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
F2: Fully vested.
F3: Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
F4: Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
F5: Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F6: Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
F7: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F8: 118 restricted stock units vest on 8/15/2026.
F9: 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
F10: 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
F11: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
F12: Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.